CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Management of Renal Dysfunction in HIV-Infected Patients Receiving Tenofovir

Last updated: March 17, 2008
Product Line: Rapid Response
Research Type: Drug
Result type: Report

Question

  1. What markers should be used to assess renal function in HIV-infected patients receiving tenofovir?
  2. What are the guidelines for management of renal dysfunction in HIV-infected patients receiving tenofovir?